Search Results - "V. N. Dvirnyk"

Differences in the Differentiation Potential and Relative Levels of Gene Expression in the Bone Marrow-Derived Fibroblast Colony-Forming Units in Patients during the Onset of Aplastic Anemia Depending on the Disease Severity by Dorofeeva, A. I., Shipunova, I. N., Luchkin, A. V., Abramova, A. V., Fidarova, Z. T., Dvirnyk, V. N., Galtseva, I. V., Mikhailova, E. A., Parovichnikova, E. N.

“…The differentiation potential of individual clones of fibroblast CFU (CFU-F) was studied and the relative expression level of genes was analyzed in the culture…”
Get full text

Morphological and immunohistochemical predictors of renal response to therapy patients with myeloma cast nephropathy and dialysis-dependent acute kidney injury by Rekhtina, I G, Kazarina, E V, Stolyarevich, E S, Kovrigina, A M, Dvirnyk, V N, Kulikov, S M, Mendeleeva, L P

“…Reveal morphological and immunohistochemical predictors of reversibility of dialysis-dependent acute kidney injury (AKI) in patients with myeloma cast…”
Get full text

Autologous haematopoietic stem cell transplantation in patients with multiple myeloma complicated by dialysis-dependent renal failure by Firsova, M V, Mendeleeva, L P, Solovev, M V, Rekhtina, I G, Pokrovskaya, O S, Urnova, E S, Soboleva, N P, Dvirnyk, V N, Klyasova, G A, Kuzmina, L A, Savchenko, V G

“…To assess the safety and efficacy of autologous haematopoietic stem cell transplantation (auto-HSCT) in multiple myeloma (MM) patients with dialysis-dependent…”
Get full text

Immunosupressive therapy of aplastic anemia patients: successes and failures (single center experiment 2007-2016) by Mikhaylova, E A, Fidarova, Z T, Abramova, A V, Luchkin, A V, Troitskaya, V V, Dvirnyk, V N, Galtseva, I V, Kliasova, G A, Kovrigina, A M, Kulikov, S M, Chabaeva, Y А, Parovichnikova, E N, Savchenko, V G, Obukhova, T N

“…Treatment programs for patients with acquired aplastic anemia include two main therapeutic options: allogeneic bone marrow transplantation and combined…”
Get full text

Immunoglobulinopathies in patients with angioimmunoblastic T-cell lymphoma by Chernova, N G, Soboleva, N P, Mariina, S A, Sidorova, Y V, Sinitsyna, M N, Dvirnyk, V N, Badmazhapova, D S, Vinogradova, Y E, Zvonkov, E E, Savchenko, V G

“…The aim of the study was to characterize quantitative and qualitative immunoglobulinopathies in patients with AITL at the onset of the disease. 55 patients…”
Get full text

COMPARATIVE ANALYSIS OF SEROLOGICAL MARKERS OF HERPES VIRUSES AND QUANTITATIVE IMMUNOGLOBULINOPATHIES IN PRIMARY PATIENTS WITH ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA by Chernova, N. G., Tihomirov, D. S., Soboleva, N. P., Mariina, S. A., Sidorova, Y. V., Sinitsyna, M. N., Dvirnyk, V. N., Kulikov, S. M., Tupoleva, T. A., Zvonkov, E. E.

“…Introduction. Angioimmunoblastic T-cell lymphoma (AITL) is associated with the Epstein-Barr virus (EBV) in most cases. It is believed polyclonal…”
Get full text

Visceral leishmaniasis concurrent with splenic marginal zone B-cell lymphoma by Julhakyan, U L, Magomedova, A U, Dvirnyk, V N, Kravchenko, S K

“…Splenic marginal zone B-cell lymphoma (SMZBCL) is a rare non-Hodgkin B-cell lymphoma that presents with morphologically mature lymphoid cells corresponding in…”
Get full text

Numbers of early CD34+ progenitors of bone marrow hematopoiesis in patients with diffuse large B-cell lymphoma by Dorokhina, E I, Magomedova, A U, Galtseva, I V, Dvirnyk, V N, Glinkina, S A, Kulikov, S M, Kravchenko, S K

“…To estimate the number of early progenitors of bone marrow (BM) hematopoiesis in patients with diffuse large B-cell lymphoma (DLBCL) in the late period after…”
Get full text

Leukemization of follicular lymphoma: The features of diagnostic and clinical course of a rare form of the disease by Nesterova, E S, Kravchenko, S K, Mangasarova, Ya K, Plastinina, L V, Dvirnyk, V N, Kovrigina, A M, Shchupletsova, I A, Obukhova, T N, Gemdzhian, E G, Vorobyev, I A, Vorobyev, A I

“…To characterize a group of patients with follicular lymphoma (FL) with leukemization and to evaluate the efficiency of different therapy options…”
Get full text

Late myelotoxicity of high-dose chemotherapy according to the modified NHL-BFM-90 program in adult patients with diffuse large B-cell lymphoma by Dorokhina, E I, Magomedova, A U, Dvirnyk, V N, Galtseva, I V, Glinkina, S A, Kulikov, S M, Obukhova, T N, Kravchenko, S K

“…to evaluate late myelotoxicity (MT) relate to high-dose chemotherapy (CT) according to the modified NHL-BFM-90 (mNHL-BFM-90) program in adult patients with…”
Get full text

Experience in investigating splenic red pulp lymphoma by Al-Radi, L S, Moiseeva, T N, Julhakyan, H L, Ntanishyan, K I, Kovrigina, A M, Glebova, S M, Lugovskaya, S A, Dvirnyk, V N, Khvastunova, A N, Yakutik, I A, Savchenko, V G

“…To generalize hematologists' experience of the diagnosis and differential diagnosis of splenic red pulp lymphoma (SRPL). Eighty-seven splenic biopsy specimens…”
Get full text

Hepatosplenic T-cell lymphoma: The problems of diagnosis and treatment by Chernova, N G, Julhakyan, H L, Vinogradova, Yu E, Sidorova, Yu V, Ryzhikova, N V, Korzhova, S M, Sinitsyna, M N, Tikhomirov, D S, Naumova, E V, Obukhova, T N, Dvirnyk, V N, Sudarikov, A B, Kovrigina, A M, Kravchenko, S K, Melikyan, A L, Kuzmina, L A, Galtseva, I V, Smirnova, S Yu, Gemdzhian, E G, Zvonkov, E E, Parovichnikova, E N, Savchenko, V G

“…In the past decade, a notable advance has been made in the understanding of the pathogenesis of NK/T-cell lymphomas; however, their diagnosis remains difficult…”
Get full text

Mastocytosis. Review of the literature and description of clinical cases by Melikian, A L, Subortseva, I N, Goriacheva, S R, Kolosheinova, T I, Vakhrusheva, M V, Kovrigina, A M, Sudarikov, A B, Dvirnyk, V N, Obukhova, T N

“…The term mastocytosis (MC) encompasses a group of rare diseases characterized by the tumorous proliferation of clonal mast cells and the infiltration of one or…”
Get full text

Synchronous and metachronous myeloid and lymphoid tumors by Melikian, A L, Kolosheĭnova, T I, Goriacheva, S R, Subortseva, I N, Vakhrusheva, M V, Kolosova, E N, Sudarikov, A B, Abdullaev, A O, Dvirnyk, V N, Varlamova, E Iu, Kovrigina, A M, Turkina, A G

“…To determine the clinical features of multiple primary tumors (MPT) in patients with hemoblastoses, to develop treatment policy for synchronous and…”
Get full text

Treatment of adult patients with acute promyelocytic leukemia according to the AIDA protocol by Parovichnikova, E N, Troitskaia, V V, Sokolov, A N, Kliasova, G A, Galstian, G M, Kuz'mina, L A, Domracheva, E V, Dvirnyk, V N, Savchenko, V G

“…To give the results of an investigation conducted at the Hematology Research Center (HRC), Ministry of Health of the Russian Federation (MHRF), to treat adult…”
Get full text

Morphological evaluation of dysmyelopoiesis in decitabine-treated patients with myelodysplastic syndromes by Dvirnyk, V N, Kokhno, A V, Glasko, E N, Gemdzhian, É G, Diagileva, O A, Platonova, T L, Parovichnikova, E N

“…To estimate a change in myelodysplasia in decitabine-treated patients with myelodysplastic syndromes (MDS). Thirteen MDS patients from a high-risk group were…”
Get full text

Successful use of vemurafenib in a patient with resistant hairy cell leukemia by Urnova, E S, Al'-Radi, L S, Kuz'mina, L A, Kariakina, A A, Kovrigina, A M, Dvirnyk, V N, Iakutik, I A, Sudarikov, A B, Parovichnikova, E N, Savchenko, V G

“…The paper describes a case of a patient with refractory hairy cell leukemia. In spite of the absence of CD25 expression, the disease was classified as a…”
Get full text

Significance of immunophenotypic, cytogenetic, and molecular markers in adult patients with T-cell lymphoblastic leukemia by Vasileva, A. N., Aleshina, O. A., Kotova, E. S., Biderman, B. V., Obukhova, T. N., Galtseva, I. V., Dvirnyk, V. N., Zakharko, E. I., Sudarikov, A. B., Parovichnikova, E. N.

“…Background. Current chemotherapy protocols for T-cell acute lymphoblastic leukemia (T-ALL) allow achieving a 5-year overall survival of 60–90 %, but relapsed…”
Get full text

Genetic landscape of acute myeloid leukemias with leukocytosis by Pekhova, K. A., Sidorova, Yu. V., Severina, N. A., Glinshchikova, O. A., Fevraleva, I. S., Biderman, B. V., Chabaeva, Yu. A., Kulikov, S. M., Luk’yanova, I. A., Kashlakova, A. I., Obukhova, T. N., Dvirnyk, V. N., Sudarikov, A. B.

“…Background.  Tumor cell proliferation in acute myeloid leukemia (AML) may manifest with high leukocyte counts. In our work, we evaluate the association of high…”
Get full text

VEGFA, VEGFR1, VEGFR2 serum and cerebrospinal fluid concentration in patients with acute leukemia by Zakharko, E. I., Dvirnyk, V. N., Chabaeva, Yu. A., Drokova, D. G., Rybkina, E. B., Lavrishinets, K. A., Bulgakov, A. V., Panasenko, M. N., Fidarova, Z. T., Lukianova, I. A., Aleshina, O. A., Kulikov, S. M., Gaponova, T. V., Troitskaya, V. V., Parovichnikova, E. N.

“…Background. Vascular endothelial growth factor A (VEGFA) is one of the most important factors for regulation of hematopoietic stem cells differentiation. It is…”
Get full text